Nu-Med Plus, Inc. NUMD
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -0.18% | -29.15% | -22.59% | -55.63% | -47.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.18% | -29.15% | -22.59% | -55.63% | -47.85% |
| Operating Income | 0.18% | 29.15% | 22.59% | 55.63% | 47.85% |
| Income Before Tax | 65.85% | 21.50% | 17.84% | 52.62% | 45.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 65.85% | 21.50% | 17.84% | 52.62% | 45.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.85% | 21.50% | 17.84% | 52.62% | 45.67% |
| EBIT | 0.18% | 29.15% | 22.59% | 55.63% | 47.85% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 50.00% | 14.29% | 25.00% | 64.29% | 57.14% |
| Normalized Basic EPS | 50.00% | 0.00% | 20.00% | 50.00% | 50.00% |
| EPS Diluted | 50.00% | 14.29% | 25.00% | 64.29% | 57.14% |
| Normalized Diluted EPS | 50.00% | 0.00% | 20.00% | 50.00% | 50.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.27% | 0.94% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.27% | 0.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |